Prostate cancer treatment in Portugal: a nationwide analysis

Autores da FMUP
Participantes de fora da FMUP
- Botelho, F
- Lopes, R
- Pina, F
- Pacheco-Figueiredo, L
Unidades de investigação
Abstract
Different treatment options exist for localized prostate cancer. Treatments performed in high-volume hospitals are associated with better results. Our objective was to describe time trends in prostate cancer treatments in Portugal and case volume per hospital. We used the national database of diagnosis-related group of the Portuguese Central Administration of the Health System to describe the number of radical prostatectomy (RP), brachytherapy (BT) and external radiotherapy (eRT) treatments performed in all National Health System hospitals. There was a rapid increase in the annual number of RP until 2006 and then a deceleration; BT treatments augmented significantly until 2011. The utilization of eRT also increased, surpassing RP after 2010. From the 46 hospitals performing RP, only eight had a case-volume > 50 treatments/year, and from the nine hospitals performing BT, only four accomplished > 15 treatments/year. In the 11 hospitals with eRT, nine performed > 50/year. Regarding RP, there was negative correlation between the hospital volume and length of stay (r = - 0.303; p = 0.041). In the Portuguese National Health Service there was a steep increase in the number of prostate cancer treatments, and there is an ample margin for concentration of RP and BT treatments, for improvement of the hospitals case volume.
Dados da publicação
- ISSN/ISSNe:
- 2045-2322, 2045-2322
- Tipo:
- Article
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
Scientific Reports Nature Publishing Group
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Keywords
- RADICAL PROSTATECTOMY; TREATMENT TRENDS; RADIOTHERAPY; SURVIVAL; VOLUME; BRACHYTHERAPY; EPIDEMIOLOGY; MANAGEMENT; PATTERNS; THERAPY
Financiamento
Proyectos asociados
Tratamento da Bexiga Hiperativa Idiopática com Toxina Botulínica: Resultados da Prática Clínica e Expectativas das Pacientes
Investigador Principal: Carlos Manuel Pires Martins da Silva
Estudo Clínico Académico (Toxina Botulínica) . 2020
Breast cancer heterogeneity - etiology, clinical management, use of health resources and survival
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2022
Longitudinal Assessment of Cognitive Decline in Breast and Prostate Cancer Survivors
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico (Cognitive Decline) . 2022
Healthcare use among cancer patients and their partners in different phases of the cancer pathway
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2021
O Papel dos Factores Neurotróficos nas Disfunções Miccionais: Implicações Fisiopatológicas e Clínicas.
Investigador Principal: Carlos Manuel Pires Martins da Silva
Estudo Clínico Académico . 2021
Reshaping organized cervical cancer screening: strategies to increase the adherence and reduce invitation costs
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
Using pooled analyses based on individual participant data for a finer assessment of gastric cancer etiology
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
RISK AND SURVIVAL OF GASTRIC CANCER RELATES SECOND PRIMARY TUMOURS: A COMPETING RISKS FRAMEWORK
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2019
Citar a publicação
Botelho F,Lopes R,Pina F,Silva C,Pacheco L,lunet N. Prostate cancer treatment in Portugal: a nationwide analysis. Sci. Rep. 2023. 13. (1):19362. IF:4,600. (2).